We found several genes (i.e., EPHAB6, SOD1, DAD1, ENDOU, FLT1, FOS, HPRT1, NPAT, OSTF1, RUBCNL and ENC1) manifesting a possible dual functionality in our GC-treated ALL cells. This evidence concerns the gene RUBCNL and acute lymphoblastic leukemia.